Daniel Spiegelman
2020
Compensation breakdown
| Salary | $449,519 |
|---|---|
| Other | $1,860,457 |
| Total | $2,309,976 |
Spiegelman received $1.9M in other compensation, accounting for 81% of the total pay in 2020.
Spiegelman also received $449.5K in salary.
Rankings
In 2020, Daniel Spiegelman's compensation ranked 4,895th out of 13,090 executives tracked by ExecPay. In other words, Spiegelman earned more than 62.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,895 out of 13,090 | 63rd |
Division Manufacturing | 1,989 out of 5,617 | 65th |
Major group Chemicals And Allied Products | 789 out of 2,248 | 65th |
Industry group Drugs | 680 out of 1,948 | 65th |
Industry Pharmaceutical Preparations | 511 out of 1,453 | 65th |
Pay ratio
| Daniel Spiegelman's Pay | $2,309,976 |
|---|---|
| Median Employee's Pay | $181,141 |
| Pay Ratio | 13to 1 |
In 2020, the annual total compensation of Daniel Spiegelman was $2,309,976.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $181,141.
The ratio of Daniel Spiegelman's pay to the pay of median employee was therefore 13 to one.
Spiegelman's colleagues
We found six more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2020.
2020
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2020
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2020
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2020
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
2020
Robert Baffi
BioMarin Pharmaceutical
Former President of Global Manufacturing and Technical Operations
2020
Jeff Ajer
BioMarin Pharmaceutical